Health policy basics: The physician payment sunshine act and the open payments program

Annals of Internal Medicine

Volumn 161, Issue 7, 2014, Pages 519-521

  Kirschner, Neil M ^a   Sulmasy, Lois Snyder ^a   Kesselheim, Aaron S ^b  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INFORMATION; MEDICAL DECISION MAKING; MEDICAL FEE; MEDICAL PRACTICE ACT; MOTIVATION; PATIENT; TEACHING HOSPITAL; DRUG INDUSTRY; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; GOVERNMENT; LEGISLATION AND JURISPRUDENCE; MANDATORY PROGRAM; MEDICAL DEVICE REGULATION; MEDICARE; PHYSICIAN; PUBLIC RELATIONS; UNITED STATES;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DRUG INDUSTRY; FINANCIAL MANAGEMENT; HEALTH POLICY; HOSPITALS, TEACHING; INTERPROFESSIONAL RELATIONS; MANDATORY PROGRAMS; MEDICAL DEVICE LEGISLATION; MEDICARE; PHYSICIANS; UNITED STATES;

EID: 84908099865     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-1303     Document Type: Article

References (10)

1. Cegedim Strategic Data. 2012 U.S. Pharmaceutical Promotion Spending. Accessed at www.skainfo.com/health-care-market-reports/2012-promotional-spending.pdf on 17 July 2014.
2. Manchanda P, Honka E. The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review. Yale J Health Policy Law Ethics. 2005;5:785-822. [PMID: 16052900]
3. Agrawal S, Brennan N, Budetti P. The Sunshine Act-effects on physicians. N Engl J Med. 2013;368:2054-7. [PMID: 23718163] doi:10.1056/NEJMp1303523
4. Coyle SL; Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396-402. [PMID:11874314]
5. Coyle SL; Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 2: organizational issues. Ann Intern Med. 2002;136:403-6. [PMID: 11874315]
6. Snyder L; American College of Physicians Ethics, Professionalism, and Human Rights Committee. American College of Physicians Ethics Manual: sixth edition. Ann Intern Med. 2012;156:73-104. [PMID: 22213573] doi:10.7326/0003-4819-156-1-201201031-00001
7. American College of Physicians. Healthcare Transparency-Focus on Price and Clinical Performance Information. Philadelphia: American Coll Physicians; 2010. Accessed at www.acponline.org/advocacy/current-policy-papers/assets/transparency.pdf on 6 June 2014.
8. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med. 2010;170: 675-82. [PMID: 20421551] doi:10.1001/archinternmed.2010.39
9. Pearson SD, Kleinman K, Rusinak D, Levinson W. A trial of disclosing physicians' financial incentives to patients. Arch Intern Med. 2006;166:623-8.[PMID: 16567600]
10. Kesselheim AS, Robertson CT, Siri K, Batra P, Franklin JM. Distributions of industry payments to Massachusetts physicians. N Engl J Med. 2013;368: 2049-52. [PMID: 23635021] doi:10.1056/NEJMp1302723